MicrobeWorld App

appsquarebannerad200x200

ASM Fellowships

Fellowship

Microbes After Hours

Watter-Supply-200x200-Banner

Click for more "Microbes After Hours" videos

Join MicrobeWorld

Subscribe via Email

subscribe

Featured Image

Featured Video

Ebola Virus explained

Supporters

ASM House 200X200

Hope for Hep C cure no excuse for risk-taking, expert warns

Professor Geoff McCaughan, head of the Liver Immunobiology Program at Sydney's Centenary Research Institute, says preliminary results of a newly developed oral treatment regime for liver transplant patients with Hepatitis C were showing promising results.

"We are starting to see some dramatic responses with these drugs," says Professor McCaughan, who also heads the liver transplant unit at the Royal Prince Alfred Hospital.

"It's too early to be certain yet, but these drugs potentially can turn around even end-stage liver disease. It's looking like they can stop the Hepatitis C virus occurring after a liver transplant, and they can get rid of the virus in people who are waiting for a transplant.
 
 

Comments (0)

Collections (0)

 

American Society for Microbiology
2012 1752 N Street, N.W. • Washington, DC 20036-2904 • (202) 737-3600
American Society For Microbiology © 2014   |   Privacy Policy   |   Terms of Use